Re:Biotech booms in China
by tpaschalis on Monday January 22, 2018 @04:17PM
(#16207993)
Isn't it possible that less regulation can help propel research, for "good" goals? I think that in 2018, novel medical applications would be far more profitable than a biological weapons, and in the end of the day, that's what matters to companies.
For example, I'm not sure that in USA it would be possible for a terminally ill patient can opt-in to a dangerous/risky/experimental new form of treatment, while it could save thousands of others if successful.
Re:Biotech booms in China
by sampo on Monday January 22, 2018 @04:45PM
(#16208205)
Even if the patient themselves agrees to the experimental treatment, but then dies, maybe even in a gruesome manner, is it still possible for the patient's family to sue the biotech startup for large sums of money?
For example, I'm not sure that in USA it would be possible for a terminally ill patient can opt-in to a dangerous/risky/experimental new form of treatment, while it could save thousands of others if successful.